Abdominal pain, a common clinical presentation, often poses a diagnostic challenge due to its diverse etiologies. A comprehensive, systematic approach is crucial for accurate diagnosis and effective management.
The initial evaluation of abdominal pain involves a thorough history and physical examination. The characteristics of the pain, such as location, duration, severity, and associated symptoms, can provide valuable clues to the underlying cause. The examination should focus on identifying signs of acute abdomen, which may necessitate immediate surgical intervention.
Investigations should be guided by the clinical suspicion. Basic investigations include complete blood count, liver function tests, renal function tests, and urinalysis. Imaging studies, such as ultrasound or computed tomography, may be required based on the suspected diagnosis. Endoscopic procedures can be useful in cases of suspected gastrointestinal pathology.
Consultation with or referral to a specialist may be required in complex cases, or when the diagnosis remains uncertain after initial evaluation and investigations. Gastroenterologists, surgeons, and gynecologists are commonly involved in the management of abdominal pain.
The management of abdominal pain is tailored to the underlying cause. It may involve medical therapy, surgical intervention, or supportive care. Patient education and reassurance also play an important role, particularly in cases of functional abdominal pain.
Evaluating abdominal pain in clinical practice requires a comprehensive approach that includes a detailed history, physical examination, appropriate investigations, and judicious use of consultation and referral. By adopting this approach, clinicians can enhance their diagnostic accuracy, improve patient outcomes, and minimize unnecessary investigations and interventions.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation